Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2024-08 · 22 (6) · 413-433
DOI: 10.6004/jnccn.2024.0040 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024-08. Verfasst von Rochelle Bagatell und 36 weiteren Autor:innen. Beteiligte Einrichtung: 1Abramson Cancer Center at the University of Pennsylvania | Children's Hospital of Philadelphia. Hauptthemen laut MEDLINE: Neuroblastoma, Medical Oncology. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 103 Literaturangaben.
Abstract (Originalsprache)
Neuroblastoma is the most common extracranial solid tumor diagnosed in children. This inaugural version of the NCCN Guidelines for Neuroblastoma provides recommendations for the diagnosis, risk classification, and treatment of neuroblastoma. The information in these guidelines was developed by the NCCN Neuroblastoma Panel, a multidisciplinary group of representatives with expertise in neuroblastoma, consisting of pediatric oncologists, radiologists, pathologists, surgeons, and radiation oncologists from NCCN Member Institutions. The evidence-based and consensus recommendations contained in the NCCN Guidelines are intended to guide clinicians in selecting the most appropriate treatments for their patients with this clinically heterogeneous disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 1Abramson Cancer Center at the University of Pennsylvania | Children's Hospital of Philadelphia.
- 2St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
- 3Johns Hopkins Kimmel Cancer Center | Johns Hopkins Children's Center.
- 4The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute | Nationwide Children's Hospital.
- 5Fred & Pamela Buffett Cancer Center | Children's Hospital & Medical Center.
- 6O'Neal Comprehensive Cancer Center at UAB | Children's of Alabama.
Zitieren
APA
Bagatell, R., Park, J. R., Acharya, S., Aldrink, J., Allison, J., Alva, E., Arndt, C., Benedetti, D., Brown, E., Cho, S., Church, A., Davidoff, A., Desai, A. V., DuBois, S., Fair, D., Farinhas, J., Harrison, D., Huang, F., Iskander, P., …, & Hang, L. (2024). Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 22(6), 413-433. https://doi.org/10.6004/jnccn.2024.0040
Vancouver
Bagatell R, Park JR, Acharya S, Aldrink J, Allison J, Alva E, et al. Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2024;22(6):413-433. doi:10.6004/jnccn.2024.0040
BibTeX
@article{Bagatell2024,
author = {Bagatell, Rochelle and Park, Julie R and Acharya, Sahaja and Aldrink, Jennifer and Allison, Jenna and Alva, Elizabeth and Arndt, Carola and Benedetti, Daniel and Brown, Erin and Cho, Steve and Church, Alanna and Davidoff, Andrew and Desai, Ami V and DuBois, Steven and Fair, Douglas and Farinhas, Joaquim and Harrison, Douglas and Huang, Frederick and Iskander, Paul and Kreissman, Susan and Macy, Margaret and Na, Brian and Pashankar, Farzana and Pendyala, Praveen and Pinto, Navin and Polites, Stephanie and Rabah, Raja and Shimada, Hiroyuki and Slatnick, Leonora and Sokol, Elizabeth and Twist, Clare and Vo, Kieuhoa and Watt, Tanya and Wolden, Suzanne and Zage, Peter and Schonfeld, Ryan and Hang, Lisa},
title = {Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2024},
volume = {22},
number = {6},
pages = {413--433},
doi = {10.6004/jnccn.2024.0040}
}
EUVIMED